cAbl-erlotinib-noxwat.mae_ligand
                    3D
 Structure written by MMmdl.
 52 54  0  0  1  0            999 V2000
  -38.3280   -7.0808  -56.6548 C   0  0  0  0  0  0
  -39.0650   -7.5408  -57.5136 C   0  0  0  0  0  0
  -39.9517   -8.1926  -58.4609 C   0  0  0  0  0  0
  -40.5352   -9.4042  -58.0996 C   0  0  0  0  0  0
  -41.4173  -10.0617  -58.9630 C   0  0  0  0  0  0
  -42.0175  -11.2762  -58.5910 N   0  0  0  0  0  0
  -42.4217  -11.7243  -57.3184 C   0  0  0  0  0  0
  -42.7193  -13.1008  -57.0893 C   0  0  0  0  0  0
  -42.6357  -14.1300  -58.0622 C   0  0  0  0  0  0
  -42.9105  -15.4633  -57.7220 C   0  0  0  0  0  0
  -42.8234  -16.5134  -58.6187 O   0  0  0  0  0  0
  -42.6281  -16.2847  -60.0143 C   0  0  0  0  0  0
  -43.8972  -15.7332  -60.7055 C   0  0  0  0  0  0
  -45.0803  -16.4589  -60.3811 O   0  0  0  0  0  0
  -45.1187  -17.8028  -60.8469 C   0  0  0  0  0  0
  -43.2696  -15.7904  -56.4088 C   0  0  0  0  0  0
  -43.4876  -17.1299  -56.1366 O   0  0  0  0  0  0
  -44.0332  -17.5182  -54.8794 C   0  0  0  0  0  0
  -44.0290  -19.0532  -54.7612 C   0  0  0  0  0  0
  -44.6874  -19.7252  -55.8310 O   0  0  0  0  0  0
  -46.0874  -19.5076  -55.9166 C   0  0  0  0  0  0
  -43.3670  -14.7844  -55.4377 C   0  0  0  0  0  0
  -43.0967  -13.4395  -55.7572 C   0  0  0  0  0  0
  -43.1888  -12.5054  -54.7696 N   0  0  0  0  0  0
  -42.9007  -11.2306  -55.1138 C   0  0  0  0  0  0
  -42.5122  -10.7974  -56.3298 N   0  0  0  0  0  0
  -41.6735   -9.5119  -60.2219 C   0  0  0  0  0  0
  -41.0859   -8.2998  -60.5929 C   0  0  0  0  0  0
  -40.2310   -7.6341  -59.7106 C   0  0  0  0  0  0
  -37.7085   -6.7099  -55.8721 H   0  0  0  0  0  0
  -40.2979   -9.8382  -57.1386 H   0  0  0  0  0  0
  -42.2612  -11.8889  -59.3541 H   0  0  0  0  0  0
  -42.3349  -13.8646  -59.0625 H   0  0  0  0  0  0
  -42.3764  -17.2500  -60.4522 H   0  0  0  0  0  0
  -41.7586  -15.6532  -60.2005 H   0  0  0  0  0  0
  -43.7603  -15.7014  -61.7874 H   0  0  0  0  0  0
  -44.0732  -14.7045  -60.3934 H   0  0  0  0  0  0
  -46.1005  -18.2273  -60.6367 H   0  0  0  0  0  0
  -44.9571  -17.8604  -61.9242 H   0  0  0  0  0  0
  -44.3795  -18.4275  -60.3449 H   0  0  0  0  0  0
  -45.0433  -17.1189  -54.7852 H   0  0  0  0  0  0
  -43.4425  -17.1204  -54.0557 H   0  0  0  0  0  0
  -44.4527  -19.3656  -53.8059 H   0  0  0  0  0  0
  -42.9951  -19.4011  -54.7624 H   0  0  0  0  0  0
  -46.5148  -20.1784  -56.6619 H   0  0  0  0  0  0
  -46.5912  -19.6944  -54.9671 H   0  0  0  0  0  0
  -46.2948  -18.4904  -56.2406 H   0  0  0  0  0  0
  -43.6304  -15.0083  -54.4163 H   0  0  0  0  0  0
  -42.9724  -10.4856  -54.3341 H   0  0  0  0  0  0
  -42.3394  -10.0123  -60.9104 H   0  0  0  0  0  0
  -41.2985   -7.8745  -61.5622 H   0  0  0  0  0  0
  -39.7897   -6.6918  -60.0013 H   0  0  0  0  0  0
  1  2  3  0  0  0
  1 30  1  0  0  0
  2  3  1  0  0  0
  3  4  2  0  0  0
  3 29  1  0  0  0
  4  5  1  0  0  0
  4 31  1  0  0  0
  5  6  1  0  0  0
  5 27  2  0  0  0
  6  7  1  0  0  0
  6 32  1  0  0  0
  7  8  1  0  0  0
  7 26  2  0  0  0
  8  9  1  0  0  0
  8 23  2  0  0  0
  9 10  2  0  0  0
  9 33  1  0  0  0
 10 11  1  0  0  0
 10 16  1  0  0  0
 11 12  1  0  0  0
 12 13  1  0  0  0
 12 34  1  0  0  0
 12 35  1  0  0  0
 13 14  1  0  0  0
 13 36  1  0  0  0
 13 37  1  0  0  0
 14 15  1  0  0  0
 15 38  1  0  0  0
 15 39  1  0  0  0
 15 40  1  0  0  0
 16 17  1  0  0  0
 16 22  2  0  0  0
 17 18  1  0  0  0
 18 19  1  0  0  0
 18 41  1  0  0  0
 18 42  1  0  0  0
 19 20  1  0  0  0
 19 43  1  0  0  0
 19 44  1  0  0  0
 20 21  1  0  0  0
 21 45  1  0  0  0
 21 46  1  0  0  0
 21 47  1  0  0  0
 22 23  1  0  0  0
 22 48  1  0  0  0
 23 24  1  0  0  0
 24 25  2  0  0  0
 25 26  1  0  0  0
 25 49  1  0  0  0
 27 28  1  0  0  0
 27 50  1  0  0  0
 28 29  2  0  0  0
 28 51  1  0  0  0
 29 52  1  0  0  0
M  END
> <s_m_entry_id>
19

> <s_m_entry_name>
cAbl-erlotinib-noxwat.1_ligand

> <s_m_subgroup_title>
cAbl-erlotinib-noxwat.mae_split_by_structure

> <s_m_subgroupid>
cAbl-erlotinib-noxwat.mae_split_by_structure

> <b_m_subgroup_collapsed>
0

$$$$
